CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method   79714-2

LOINC Code


LOINC code79714-2
nameCYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
descriptionThe CYP2C19 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting CYP2C19 gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]
statusACTIVE

Fully-Specified Name

componentCYP2C19 gene product metabolic activity interpretation
propertyImp  =  Impression/interpretation of study
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemBld/Tiss
    Bld  =  Whole blood
    Tiss  =  Tissue, unspecified
scaleOrd  =  Ordinal:  Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive.
methodMolgen  =  Molecular Genetics:  General class of methods used to detect genetic attributes on a molecular basis including RFL, PCR and other methods.

Additional Names

short nameCYP2C19 gene prod met act imp Bld/T-Imp

Basic Attributes

classMOLPATH.PHARMG
type1  Laboratory
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

72886-5CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method

History/Usage

test rank10495 of 2000 most commonly performed tests by labs in USA
first released
last updated2.73
last change typeMIN  - change to field other than name

Related Names

Activ
Actvty
Blood
CPCJ
CYP2C
CYP2C19 gene prod met act imp
CYPIIC17
CYPIIC19
cytochrome P-450 II C
cytochrome P450, family 2, subfamily C, polypeptide 19
Drug metabolism
Gene prod met act imp
Impression
Impression/interpretation of study
Impressions
Interp
Interpret
Interpretation
Interpt
Intrp
Molecular genetics
Molecular pathology
MOLPATH
MOLPATH.PHARMG
Movements
Ordinal
P450C2C
P450IIC19
PCR
Phenotype
Point in time
QL
Qual
Qualitative
Random
Screen
Tissue
Tissue, unspecified
WB
Whole blood
Whole blood or Tissue

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.